Unknown PHASE4 INTERVENTIONAL 2-arm NCT03051503

Efficacy of Transdermal Fentanyl Patches in Relief of Acute Postoperative Pain After Mastectomy

Sponsor: South Egypt Cancer Institute

Interventions Intravenous patient-controlled analgesia (PCA) morphine The Transdermal Therapeutic System-Fentanyl (TTS-F)

Updated 8 times since 2017 Last updated: Feb 22, 2017 Started: Feb 2, 2017 Primary completion: Apr 30, 2017 Completion: Apr 30, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03051503, this PHASE4 trial focuses on Breast Cancer Female and remains ongoing. Sponsored by South Egypt Cancer Institute, it has been updated 8 times since 2017, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE4
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Mar 2019 — Jan 2021 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status

▶ Show 3 earlier versions

Jun 2018 — Mar 2019 [monthly]

Recruiting PHASE4
Mar 2017 — Jun 2018 [monthly]

Recruiting PHASE4
Feb 2017 — Mar 2017 [monthly]

Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

South Egypt Cancer Institute

Data source: South Egypt Cancer Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Asyut, Egypt